These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 37478687

  • 1. Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic.
    Hallam TM, Sharp SJ, Andreadi A, Kavanagh D.
    Immunobiology; 2023 Sep; 228(5):152410. PubMed ID: 37478687
    [Abstract] [Full Text] [Related]

  • 2. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.
    Geerlings MJ, Volokhina EB, de Jong EK, van de Kar N, Pauper M, Hoyng CB, van den Heuvel LP, den Hollander AI.
    Clin Genet; 2018 Oct; 94(3-4):330-338. PubMed ID: 29888403
    [Abstract] [Full Text] [Related]

  • 3. A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration.
    Hallam TM, Cox TE, Smith-Jackson K, Brocklebank V, Baral AJ, Tzoumas N, Steel DH, Wong EKS, Shuttleworth VG, Lotery AJ, Harris CL, Marchbank KJ, Kavanagh D.
    Front Immunol; 2022 Oct; 13():1028760. PubMed ID: 36643920
    [Abstract] [Full Text] [Related]

  • 4. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
    Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, Goodship JA, Fremeaux-Bacchi V, Remuzzi G, Goodship TH, Atkinson JP.
    Mol Immunol; 2008 Jan; 45(1):95-105. PubMed ID: 17597211
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort.
    Hallam TM, Andreadi A, Sharp SJ, Brocklebank V, Gardenal E, Dreismann A, SCOPE Study Group, Lotery AJ, Marchbank KJ, Harris CL, Jones AV, Kavanagh D.
    J Biol Chem; 2024 Jul; 300(7):107452. PubMed ID: 38852887
    [Abstract] [Full Text] [Related]

  • 6. Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome.
    de Jong S, de Breuk A, Bakker B, Katti S, Hoyng CB, Nilsson SC, Blom AM, van den Heuvel LP, den Hollander AI, Volokhina EB.
    Front Immunol; 2021 Jul; 12():789897. PubMed ID: 35069568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM.
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [Abstract] [Full Text] [Related]

  • 9. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.
    J Immunol; 2018 Apr 01; 200(7):2464-2478. PubMed ID: 29500241
    [Abstract] [Full Text] [Related]

  • 10. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I.
    Nilsson SC, Kalchishkova N, Trouw LA, Fremeaux-Bacchi V, Villoutreix BO, Blom AM.
    Eur J Immunol; 2010 Jan 01; 40(1):172-85. PubMed ID: 19877009
    [Abstract] [Full Text] [Related]

  • 11. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R, Heurich M, López-Perrote A, Tortajada A, Pinto S, López-Trascasa M, Sánchez-Corral P, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba S.
    Mol Immunol; 2015 Aug 01; 66(2):263-73. PubMed ID: 25879158
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
    Nozal P, Garrido S, Alba-Domínguez M, Espinosa L, Peña A, Córdoba SR, Sánchez-Corral P, López-Trascasa M.
    Mol Immunol; 2014 Apr 01; 58(2):194-200. PubMed ID: 24378252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complement factor I in health and disease.
    Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM.
    Mol Immunol; 2011 Aug 01; 48(14):1611-20. PubMed ID: 21529951
    [Abstract] [Full Text] [Related]

  • 17. Effect of rare coding variants in the CFI gene on Factor I expression levels.
    de Jong S, Volokhina EB, de Breuk A, Nilsson SC, de Jong EK, van der Kar NCAJ, Bakker B, Hoyng CB, van den Heuvel LP, Blom AM, den Hollander AI.
    Hum Mol Genet; 2020 Aug 11; 29(14):2313-2324. PubMed ID: 32510551
    [Abstract] [Full Text] [Related]

  • 18. Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.
    Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP.
    Clin Exp Immunol; 2015 Aug 11; 181(2):306-13. PubMed ID: 25079699
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.
    Schramm EC, Roumenina LT, Rybkine T, Chauvet S, Vieira-Martins P, Hue C, Maga T, Valoti E, Wilson V, Jokiranta S, Smith RJ, Noris M, Goodship T, Atkinson JP, Fremeaux-Bacchi V.
    Blood; 2015 Apr 09; 125(15):2359-69. PubMed ID: 25608561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.